Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Wolkenstein

Showing results (41-50 of 230) with videos related to

Pageof 23
Sort By:
Contact Dermatitis|April 14, 2020
Strong reactions to diltiazem patch tests: Plea for a low concentrationHaudrey Assier, Saskia Ingen-Housz-Oro, Ouidad Zehou, et al.
Plastic and Reconstructive Surgery|March 26, 2010
Facial aesthetic unit remodeling procedure for neurofibromatosis type 1 hemifacial hypertrophy: report on 33 consecutive adult patientsMikaël Hivelin, Pierre Wolkenstein, Christophe Lepage, et al.
Dermatology (Basel, Switzerland)|December 18, 2008
Health-related quality of life in patients with neurofibromatosis type 1. A survey of 129 Italian patientsYllka Kodra, Sandra Giustini, Luigina Divona, et al.
Journal of the American Academy of Dermatology|July 21, 2015
Low-dose methotrexate-induced skin toxicity: Keratinocyte dystrophy as a histologic markerJulie Delyon, Nicolas Ortonne, Emmanuel Benayoun, et al.
Journal of the American Academy of Dermatology|July 18, 2006
A survey on the prevalence of orofacial herpes in France: the INSTANT StudyGérard Lorette, Anne Crochard, Viviane Mimaud, et al.
JAMA Dermatology|January 18, 2013
Levetiracetam: a possible new inducer of toxic epidermal necrolysis and Stevens-Johnson syndrome in 2 casesTu Anh Duong, Cynthia Haddad, Laurence Valeyrie-Allanore, et al.
Operative Neurosurgery (Hagerstown, Md.)|April 28, 2025
Surgical Management of Peripheral Nerve Schwannomas in Non-Neurofibromatosis Type 2 SchwannomatosisMatthieu Peyre, Alix Addi, Béatrice Parfait, et al.
Virchows Archiv : an International Journal of Pathology|September 26, 2003
Aberrant axon neurofilaments in schwannomas associated with phacomatosesJanine Wechsler, Laurent Lantieri, Jacques Zeller, et al.
Contact Dermatitis|July 22, 2017
Patch testing in non-immediate cutaneous adverse drug reactions: value of extemporaneous patch testsHaudrey Assier, Laurence Valeyrie-Allanore, Gwendeline Gener, et al.
The British Journal of Dermatology|October 8, 2024
Diagnostic value of three complete blood count abnormalities, hypereosinophilia, hyperlymphocytosis and basophilic lymphocytes, in Drug Reaction with Eosinophilia and Systemic SymptomsPatti Carmela Liccardo, Saskia Ingen-Housz-Oro, Pierre Wolkenstein, et al.
Pageof 23

Showing results (41-50 of 230) with videos related to

Sort By:
Pageof 23
Contact Dermatitis|April 14, 2020
Strong reactions to diltiazem patch tests: Plea for a low concentrationHaudrey Assier, Saskia Ingen-Housz-Oro, Ouidad Zehou, et al.
Plastic and Reconstructive Surgery|March 26, 2010
Facial aesthetic unit remodeling procedure for neurofibromatosis type 1 hemifacial hypertrophy: report on 33 consecutive adult patientsMikaël Hivelin, Pierre Wolkenstein, Christophe Lepage, et al.
Dermatology (Basel, Switzerland)|December 18, 2008
Health-related quality of life in patients with neurofibromatosis type 1. A survey of 129 Italian patientsYllka Kodra, Sandra Giustini, Luigina Divona, et al.
Journal of the American Academy of Dermatology|July 21, 2015
Low-dose methotrexate-induced skin toxicity: Keratinocyte dystrophy as a histologic markerJulie Delyon, Nicolas Ortonne, Emmanuel Benayoun, et al.
Journal of the American Academy of Dermatology|July 18, 2006
A survey on the prevalence of orofacial herpes in France: the INSTANT StudyGérard Lorette, Anne Crochard, Viviane Mimaud, et al.
JAMA Dermatology|January 18, 2013
Levetiracetam: a possible new inducer of toxic epidermal necrolysis and Stevens-Johnson syndrome in 2 casesTu Anh Duong, Cynthia Haddad, Laurence Valeyrie-Allanore, et al.
Operative Neurosurgery (Hagerstown, Md.)|April 28, 2025
Surgical Management of Peripheral Nerve Schwannomas in Non-Neurofibromatosis Type 2 SchwannomatosisMatthieu Peyre, Alix Addi, Béatrice Parfait, et al.
Virchows Archiv : an International Journal of Pathology|September 26, 2003
Aberrant axon neurofilaments in schwannomas associated with phacomatosesJanine Wechsler, Laurent Lantieri, Jacques Zeller, et al.
Contact Dermatitis|July 22, 2017
Patch testing in non-immediate cutaneous adverse drug reactions: value of extemporaneous patch testsHaudrey Assier, Laurence Valeyrie-Allanore, Gwendeline Gener, et al.
The British Journal of Dermatology|October 8, 2024
Diagnostic value of three complete blood count abnormalities, hypereosinophilia, hyperlymphocytosis and basophilic lymphocytes, in Drug Reaction with Eosinophilia and Systemic SymptomsPatti Carmela Liccardo, Saskia Ingen-Housz-Oro, Pierre Wolkenstein, et al.
Pageof 23